1. Home >
  2. M&A >
  3. Venture >
  4. United States >
  5. North Carolina >
  6. Anzu Partners Invests In Codetta Bio

Investment Summary

Anzu Partners Invests In Codetta Bio

On June 1, 2021, growth capital firm Anzu Partners invested in life science company Codetta Bio

Investment Highlights
  • This is Anzu Partners’ 10th transaction in the Life Science sector.
  • This is Anzu Partners’ 22nd transaction in the United States.
  • This is Anzu Partners’ 2nd transaction in North Carolina.

Investment Summary
Date 2021-06-01
Target Codetta Bio
Sector Life Science
Investor(s) Anzu Partners
Deal Type Venture

Target

Codetta Bio

Morrisville, North Carolina, United States
Codetta Bio is a life sciences company developing a unique digital spatial polymerase chain reaction (dsPCR) and digital spatial immuno polymerase chain reaction (dsiPCR) platform for multi-omic analysis from a single specimen. Codetta’s integrated platform of reagents, hardware, and software enables simultaneous, multi-plexed, and multi-omic analyses of liquid biopsy and isolated DNA, RNA and protein. Codetta Bio was founded in 2021 and is based in Morrisville, North Carolina.

Search 214,238 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Investor(S) 1

Investor

Anzu Partners

Investor Investor Investor Investor Investor

Category Growth Capital Firm
Founded 2014
PE ASSETS 1.0B USD
Size Middle-Market
Type Sector Agnostic
DESCRIPTION

Anzu Partners is a venture capital and private equity firm that looks to develop and commercialize technological advancements in manufacturing, materials, monitoring/measurement, and modeling. This includes 3D printing, robotics, nanotechnology, composites, sensors, AI, and analytics. Anzu Partners was formed in 2014 and is headquartered in Boston, Massachusetts.

DEAL STATS #
Overall 25 of 36
Sector: Life Science M&A 10 of 11
Type: Venture M&A Deals 23 of 32
State: North Carolina M&A 2 of 2
Country: United States M&A 22 of 30
Year: 2021 M&A 2 of 4
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2021-02-17 Excision BioTherapeutics

Watertown, Massachusetts, United States

Excision BioTherapeutics is a biotechnology company developing CRISPR-based therapies to cure viral infection diseases and improve the lives of chronically ill patients. Excision BioTherapeutics was founded in 2015 and is based in Watertown, Massachusetts.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2021-11-23 Xendee

La Jolla, California, United States

Xendee develops distributed energy resources (DER) planning and operation software for project decision support, planning, design, resilience, and real-time operation. Xendee was founded in 2018 and is based in La Jolla, California.

Buy -
Mergr

Solution for

Product

Company

Legal